In adults with CKM syndrome, finerenone vs. placebo reduced sudden death at a median 2.9 y.
Where this comes from
- Record sourced from PubMed, PMID 42673602.
- Also identified by DOI 10.7326/ANNALS-26-03105-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text] Endocrinology: [Formula: see text] Nephrology: [Formula: see text].